European Union regulators will review new information relating to the safety of Eisai Co.’s and Biogen Inc.’s medicine for ...
One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...
A recent study from Karolinska Institutet suggests that a type of diabetes medication called GLP-1 agonists could reduce the ...
His geriatric doctor said "no" to prescribing medication to help slow down the disease. The doctor said his pulse rate is low ...
Antimicrobials, vaccines, and anti-inflammatories associated with reduced risk for Alzheimer disease and dementia.
Fact checked by Nick Blackmer The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for ...
Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...
The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...
There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback